Multidrug treatment for COVID-19
M Ohe, K Furuya, H Goudarzi - Drug Discoveries & Therapeutics, 2021 - jstage.jst.go.jp
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
which began in Wuhan, China in December 2019, has rapidly spread all over the world. The …
which began in Wuhan, China in December 2019, has rapidly spread all over the world. The …
[HTML][HTML] Oxytocin, the panacea for long-COVID? a review
Objectives In this hypothesis paper we explore the underlying mechanisms for long-COVID
and how the oxytocinergic neurones could be infected by SARS-CoV-2 leading to a …
and how the oxytocinergic neurones could be infected by SARS-CoV-2 leading to a …
[HTML][HTML] Efficacy and limitations of repurposed drugs and vaccines for COVID-19
N Murmu, M Sarkar, S Dey, R Manna, S Roy… - Journal of Medicine …, 2023 - Elsevier
ABSTRACT COVID-19 is a contagious, severe acute respiratory disease caused by the
coronavirus named SARS-CoV-2. In this review, we have updated the nature and evolution …
coronavirus named SARS-CoV-2. In this review, we have updated the nature and evolution …
[PDF][PDF] Пандемия COVID-19: актуальные вызовы времени, а также новейшие данные к вопросу рационального выбора психофармакотерапии у пациентов с …
НН Петрова, ПВ Морозов, АВ Маркин… - Психиатрия и …, 2020 - academia.edu
Резюме Бушующая в последний год во всем мире пандемия COVID-19 привела к
резкому ухудшению психического здоровья и психологического благополучия всей …
резкому ухудшению психического здоровья и психологического благополучия всей …
[PDF][PDF] Treatment modalities of the covid-19 pandemic through repurposed drugs and status of vaccines
MS Hussain, PP Mohit… - International Journal of …, 2021 - pdfs.semanticscholar.org
Respiratory diseases are the leading source of morbidity and death for millions around the
world of all ages. A 2019 coronavirus outbreak has occurred in China and is spread quickly …
world of all ages. A 2019 coronavirus outbreak has occurred in China and is spread quickly …
[HTML][HTML] Uso de psicofármacos para síntomas neuropsiquiátricos en pacientes hospitalizados con COVID-19
G Valdivieso-Jiménez - Horizonte Médico (Lima), 2021 - scielo.org.pe
La pandemia por la COVID-19 es la actual crisis sanitaria mundial que, hasta la fecha, ha
cobrado miles de vidas en la mayoría de los países. Desde inicios del 2020 se estudia el …
cobrado miles de vidas en la mayoría de los países. Desde inicios del 2020 se estudia el …
Therapeutic Strategies in the Management of COVID-19
Since December 2019, SARS-CoV-2 (COVID-19), novel corona virus has caused pandemic
globally, with rise in the number of cases and death of the patients. Vast majority of the …
globally, with rise in the number of cases and death of the patients. Vast majority of the …
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
The global COVID-19 pandemic has affected the world's population by causing changes in
behavior, such as social distancing, masking, restricting people's movement, and evaluating …
behavior, such as social distancing, masking, restricting people's movement, and evaluating …
Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks
J Xu, R Abdulsalam Khaleel, HK Zaidan… - Cell Cycle, 2024 - Taylor & Francis
ABSTRACT Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of …
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of …
Uso de ivermectina en pacientes con la COVID-19: Una revision narrativa
E Castañeda-Marín, A Gonzalez-Gonzalez… - Revista del Cuerpo …, 2020 - scielo.org.pe
Introducción. Hacia finales del último mes del 2019, se identificó un nuevo coronavirus
altamente contagioso en China provocando el inicio de una nueva pandemia. Millones de …
altamente contagioso en China provocando el inicio de una nueva pandemia. Millones de …